New Opioids Findings from University of Massachusetts Outlined (Endocannabinoid Agonist 2-arachidonoylglycerol Differentially Alters Diurnal Activity and Sleep During Fentanyl Withdrawal In Male and Female Mice)

MLA

“New Opioids Findings from University of Massachusetts Outlined (Endocannabinoid Agonist 2-Arachidonoylglycerol Differentially Alters Diurnal Activity and Sleep During Fentanyl Withdrawal In Male and Female Mice).” Obesity, Fitness & Wellness Week, Sept. 2024, p. 2012. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsggo&AN=edsgcl.809525889&authtype=sso&custid=ns315887.

APA

New Opioids Findings from University of Massachusetts Outlined (Endocannabinoid Agonist 2-arachidonoylglycerol Differentially Alters Diurnal Activity and Sleep During Fentanyl Withdrawal In Male and Female Mice). (2024, September 28). Obesity, Fitness & Wellness Week, 2012.

Chicago

Obesity, Fitness & Wellness Week. 2024. “New Opioids Findings from University of Massachusetts Outlined (Endocannabinoid Agonist 2-Arachidonoylglycerol Differentially Alters Diurnal Activity and Sleep During Fentanyl Withdrawal In Male and Female Mice),” September 28. http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsggo&AN=edsgcl.809525889&authtype=sso&custid=ns315887.